Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Chiome Bioscience Inc. ( (JP:4583) ).
Chiome Bioscience Inc. reported its financial results for the first quarter of 2025, showing a slight increase in net sales compared to the previous year but continued to incur losses. The company maintained its dividend forecast at zero and only disclosed business forecasts for its Drug Discovery Support Business, citing difficulties in estimating its Drug Discovery and Development Business. The financial position showed a decrease in total assets and net assets, with a slight improvement in the equity ratio.
More about Chiome Bioscience Inc.
Chiome Bioscience Inc. operates in the biotechnology industry, focusing on drug discovery and development. The company is listed on the Tokyo Stock Exchange and is involved in providing drug discovery support services.
Average Trading Volume: 2,065,794
Technical Sentiment Signal: Strong Sell
Current Market Cap: Yen9.39B
Learn more about 4583 stock on TipRanks’ Stock Analysis page.